To identify a set of biomarkers suitable for monitoring progression of IBD to CRC, RUNX1 was further tested in combination with four known CRC biomarkers (CEA, TIMP1, CA724, CA199). The gene discussed is RUNX1; the disease is inflammatory bowel disease.